Cholesterol And Lipids In Depression: Stress, Hypothalamo-Pituitary-Adrenocortical Axis, And Inflammation/Immunity

Advances in Clinical Chemistry

Volumn 39, Issue , 2005, Pages 81-105

  Huang, Tiao Lai ^a   Chen, Jung Fu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ANIMAL; DEPRESSION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; INNATE IMMUNITY; LIPID METABOLISM; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; REVIEW; STRESS;

ANIMALS; CHOLESTEROL; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNITY, NATURAL; INFLAMMATION; LIPID METABOLISM; PHENOTYPE; PITUITARY-ADRENAL SYSTEM; STRESS;

EID: 23244439601     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(04)39003-7     Document Type: Review

References (156)

1. Boston P.F., Dursun S.M., and Reveley M.A. Cholesterol and mental disorder. Br J Psychiatry 169 (1996) 682-689
2. Golomb B.A. Cholesterol and violence: Is there a connection?. Ann Int Med 128 (1998) 478-487
3. Muldoon M.F., Manuck S.B., Mendelsohn A.B., Kaplan J.R., and Belle S. Cholesterol reduction and non-illness mortality: Meta-analysis of randomized clinical trials. BMJ 322 (2001) 11-15
4. Engelberg H. Low serum cholesterol and suicide. Lancet 339 (1992) 727-729
5. Hawton K., Cowen P., Owens D., Bond A., and Elliott M. Low serum cholesterol and suicide. Br J Psychiatry 162 (1993) 818-825
6. Steegmans P.H., Fekkes D., Hoes A.W., Bak A.A., van der Does E., and Grobbee D.E. Low serum cholesterol concentration and serotonin metabolism in men. BMJ 312 (1996) 221
7. Alvarez J.C., Cremniter D., Gluck N., et al. Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res 95 (2000) 103-108
8. Comings D.E., MacMurray J.P., Gonzalez N., Ferry L., and Peters W. Association of the serotonin transporter gene with serum cholesterol levels and heart disease. Mol Genet Metab 67 (1999) 248-253
9. Collier D.A., Stober G., Li T., et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Mol Psychiatry 1 (1996) 453-460
10. Du L., Faludi G., Palkovits M., et al. Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol Psychiatry 46 (1999) 196-201
11. Bocchetta A., Chillotti C., Carboni G., Oi A., Ponti M., and Del Zompo M. Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients. Acta Psychiatr Scand 104 (2001) 37-41
12. Kim Y.K., and Myint A.M. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord 81 (2004) 161-166
13. Terao T., Yoshimura R., Ohmori O., et al. Effects of serum cholesterol levels of meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects. Biol Psychiatry 41 (1997) 974-978
14. Sarchiapone M., Camardese G., Roy A., et al. Cholesterol and serotonin indices in depressed and suicidal patients. J Affect Disord 62 (2001) 217-219
15. Penttinen J. Hypothesis: Low cholesterol, suicide and interleukin-2. Am J Epidemiol 141 (1996) 716-718
16. Myint Am., and Kim Y.K. Cytokine-serotonin interaction through IDO: A neurodegeneration of depression. Med Hypotheses 61 (2003) 519-525
17. Anisman H., and Merali Z. Cytokines, stress and depressive illness: Brain-immune interactions. Ann Med 35 (2003) 2-11
18. Pariante C.M., and Miller A.H. Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biol Psychiatry 49 (2001) 391-404
19. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 29 (2004) 185-193
20. Nemeroff C.B. Neurobiological consequences of childhood trauma. J Clin Psychiatry 65 Suppl. 1 (2004) 18-28
21. Morgan R.E., Palinkas L.A., Barrett-Connor E.L., and Wingard D.L. Plasma cholesterol and depressive symptoms in older men. Lancet 341 (1993) 75-79
22. Terao T., Iwata N., Kanazawa K., et al. Low serum cholesterol levels and depressive state in human dock visitors. Acta Psychiatr Scand 101 (2000) 231-234
23. Swartz C.M. Albumin decrement in depression and cholesterol decrement in mania. J Affect Disord 19 (1990) 173-176
24. Bajwa W.K., Asnis G.M., Sanderson W.C., Irfan A., and van Praag H.M. High cholesterol levels in patients with panic disorder. Am J Psychiatry 149 (1992) 376-378
25. Maes M., Delanghe J., Meltzer H.Y., et al. Lower degree of esterification of serum cholesterol in depression: Relevance for depression and suicide research. Acta Psychiatr Scand 90 (1994) 252-258
26. McCallum J., Simons L., Simons J., and Friedlander Y. Low serum cholesterol is not associated with depression in the elderly: Data from an Australian community study. Aus NZ J Med 24 (1994) 561-564
27. Troisi A., Scucchi S., San Martino L., Montera P., d'Amore A., and Moles A. Age specificity of the relationship between serum cholesterol and mood in obese women. Physiol Behav 72 (2001) 409-413
28. Hu P., Seeman T.E., Harris T.B., and Reuben D.B. Does inflammation or undernutrition explain the low cholesterol-mortality association in high-functioning older persons? MacArthur studies of successful aging. J Am Geriatr Soc 51 (2003) 80-84
29. Nakao M., Ando K., Nomura S., et al. Depressive mood accompanies hypercholesterolemia in young Japanese adults. Jpn Heart J 42 (2001) 739-748
30. Glueck C.J., Kuller F.E., Hamer T., et al. Hypocholesterolemia, hypertriglyceridemia, suicide, and suicide ideation in children hospitalized for psychiatric diseases. Pediatr Res 35 (1994) 602-610
31. Lindberg G., Larsson G., Setterlind S., and Rastam L. Serum lipids and mood in working men and women in Sweden. J Epidemiol Community Health 48 (1994) 360-363
32. Chen C.C., Lu F.H., Wu J.S., and Chang C.J. Correlation between serum lipid concentrations and psychological distress. Psychiatry Res 93 (2001) 93-102
33. Huang T.L., Wu S.C., Chiang Y.S., and Chen J.F. Correlation between serum lipid, lipoprotein concentrations and anxious state, depressive state or major depressive disorder. Psychiatry Res 118 (2003) 147-153
34. Glueck C.J., Tieger M., Kunkel R., Hamer T., Tracy T., and Speirs J. Hypocholesterolemia and affective disorders. Am J Med 308 (1994) 218-225
35. Olusi S.O., and Fido A.A. Serum lipid concentrations in patients with major depressive disorder. Biol Psychiatry 40 (1996) 1128-1131
36. Maes M., Smith R., Christophe, A, et al. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: Relationship with immune-inflammatory markers. Acta Psychiatr Scand 95 (1997) 212-221
37. Partonen T., Haukka J., Virtamo J., Taylor P.R., and Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry 175 (1999) 259-262
38. Huang T.L. Serum cholesterol levels in mood disorders associated with physical violence or suicide attempts in Taiwanese. Chang Gung Med J 24 (2001) 563-568
39. Brown S.L., Salive M.E., Harris T.B., Simonsick E.M., Guralnik J.M., and Kohout F.J. Low cholesterol concentrations and severe depressive symptoms in elder people. BMJ 308 (1994) 1328-1332
40. Apter A., Laufer N., Bar-Sever M., Har-Even D., Ofek H., and Weizman A. Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in adolescent psychiatric inpatients. Biol Psychiatry 46 (1999) 532-541
41. Huang T.L., and Chen J.F. Lipid and lipoprotein levels in depressive disorders with melancholic feature or atypical feature and dysthymia. Psychiatry Clin Neurosci 58 (2004) 295-299
42. Kimmel P.L., Weihs K., and Peterson R.A. Survival in hemodialysis patients: The role of depression. J Am Soc Nephrol 3 (1993) 12-27
43. Frasure-Smith N., Lesperance F., and Talajic M. Depression following myocardial infarction: Impact of 6-month survival. JAMA 270 (1993) 1819-1825
44. Barefoot J.C., and Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93 (1996) 1976-1980
45. Penninx B.W.J.H., Beekman A.T.F., Honig A., et al. Depression and cardiac mortality: Results from a community-based longitudinal study. Arch Gen Psychiatry 58 (2001) 221-227
46. Coelho R., Ramos E., Prata J., and Barros H. Psychosocial indexes and cardiovascular risk factors in a community sample. Psychother Psychosom 69 (2000) 261-274
47. van Doornen L.J., and van Blokland R.W. The relation of type A behavior and vital exhaustion with physiological reactions to real life stress. J Psychosom Res 33 (1989) 715-725
48. Rutledge T., Reis S.E., Olson M., et al. Psychosocial variables are associated with atherosclerosis risk factors among women with chest pain: The WISE study. Psychosom Med 63 (2001) 282-288
49. Su C.T. Association between job strain status and cardiovascular risk in a population of Taiwanese white-collar workers. Jpn Circ J 65 (2001) 509-513
50. Engstrom G., Lind P., Hedblad B., Stavenow L., Janzon L., and Lindgarde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 105 (2002) 2632-2637
51. Jialal I., and Devaraj S. Inflammation and atherosclerosis: The value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol 116 Suppl. (2001) S108-S115
52. Yetiv J.Z. Clinical applications of fish oils. JAMA 260 (1988) 665-670
53. Shibata H., Kumagai S., Watanabe S., and Suzuki T. Relationship of serum cholesterols and vitamin E to depressive status in the elderly. J Epidemiol 9 (1999) 261-267
54. Rogers P.J. A healthy body, a healthy mind: Long-term impact of diet on mood and cognitive function. Proc Nutr Soc 60 (2001) 135-143
55. Lutjohann D., Papassotiropoulos A., Bjorkhem I., et al. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 41 (2000) 195-198
56. Curtiss L.K., and Boisvert W.A. Apolipoprotein E and atherosclerosis. Curr Opin Lipidol 11 (2000) 243-251
57. Brahimi F., Bertrand P., Starck M., Galteau M.M., and Siest G. Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2. Cell Biochem Funct 19 (2001) 51-58
58. Teunissen C.E., de Vente J., Steinbusch H.W., and De Bruijn C. Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol Aging 23 (2002) 485-508
59. Katon W.J. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54 (2003) 216-226
60. Harris M.D. Psychosocial aspects of diabetes with an emphasis on depression. Curr Diab Rep 3 (2003) 49-55
61. Nosadini R., Manzato E., Solini A., et al. Peripheral, rather than hepatic, insulin resistance and atherogenic lipoprotein phenotype predict cardiovascular complications in NIDDM. Eur J Clin Invest 24 (1994) 258-266
62. Helkala E.L., Niskanen L., Viinamaki H., Partanen J., and Uusitupa M. Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care 18 (1995) 681-685
63. Kimmel P.L., Patel S.S., and Peterson R.A. Depression in African-American patients with kidney disease. J Nati Med Assoc 94 Suppl. (2002) S92-S103
64. Kaysen G.A., Gambertoglio J., Felts J., and Hutchison F.N. Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients. Kid Int 31 (1987) 1368-1376
65. Nihei T., Miura Y., and Yagasaki K. Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats. Life Sci 68 (2001) 2845-2852
66. Bruno C.M., Meli S., Marcinno M., Ierna D., Sciacca C., and Neri S. Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients. J Biol Regul Homeost Agents 16 (2002) 114-117
67. Huang T.L., and Lee C.T. Serum albumin and ferritin levels in chronic hemodialysis patients with or without major depression. International Congress of Biological Psychiatry, February 9-13, 2004. Sydney (2004) abstract 88.
68. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
69. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
70. Chiba M., Suzuki S., Hinokio Y., et al. Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism 49 (2000) 1145-1149
71. Stewart T.D., and Atlas S.A. Syndrome X, depression, and chaos: Relevance to medical practice. Conn Med 64 (2000) 343-345
72. Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Morales P.A., and Stern M.P. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41 (1992) 715-722
73. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
74. Lawlor D.A., Smith G.D., and Ebrahim S. British Women's Heart and Health Study. Association of insulin resistance with depression: Cross sectional findings from the British Women's Heart and Health Study. BMJ 327 (2003) 1383-1384
75. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
76. Ramasubbu R. Insulin resistance: A metabolic link between depressive disorder and atherosclerotic vascular diseases. Med Hypotheses 59 (2002) 537-551
77. Schwertner H.A., Torres L., Jackson W.G., Maldonado H.A., Whitson J.D., and Troxler R.G. Cortisol and the hypercholesterolemia of pregnancy and labor. Atherosclerosis 67 (1987) 237-244
78. Troisi A., Moles A., Panepuccia L., Lo Russo D., Palla G., and Scucchi S. Serum cholesterol levels and mood symptoms in the postpartum period. Psychiatry Res 109 (2002) 213-219
79. Nasta M.T., Grussu P., Quatraro R.M., Cerutti R., and Grella P.V. Cholesterol and mood states at 3 days after delivery. J Psychosom Res 52 (2002) 61-63
80. West S.G., Hinderliter A.L., Wells E.C., Girdler S.S., and Light K.C. Transdermal estrogen reduces vascular resistance and serum cholesterol in postmenopausal women. Am J Obstet Gynecol 184 (2001) 926-933
81. Muldoon M.F., Manuck S.B., and Matthews K.A. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. BMJ 301 (1990) 309-314
82. Lindberg G., Rastam L., Gullberg B., and Ekulund G.A. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ 305 (1992) 277-279
83. Neaton J.D., Blackburn H., Jacobs D., et al. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Arch Int Med 152 (1992) 1490-1500
84. Zureik M., Courbon D., and Ducimetiere P. Serum cholesterol concentration and death from suicide in men. BMJ 313 (1996) 649-651
85. Kunugi H., Takei N., Aoki H., and Nanko S. Low serum cholesterol in suicide attempter. Biol Psychiatry 41 (1997) 196-200
86. Pekkanen J., Nissinen A., Punsar S., and Karvonen M.J. Serum cholesterol and risk of accidental or violent death in a 25-year follow-up: The Finnish cohorts of the Seven Countries Study. Arch Int Med 149 (1989) 1589-1591
87. Jacobs D., Blackburn H., Higgins M., et al. Report of the conference on low blood cholesterol: Mortality associations. Circulation 86 (1992) 1046-1060
88. Vartiainen E., Puska P., Pekkanen J., Tuomilehto J., Lonnqvist J., and Ehnholm C. Serum cholesterol and accidental or other violent deaths. BMJ 309 (1994) 445-447
89. Tanskanen A., Vartiainen E., Tuomilehto J., Viinamaki H., Lehtonen J., and Puska P. High serum cholesterol and risk of suicide. Am J Psychiatry 157 (2000) 648-650
90. Fawcett J., Busch K.A., Jacobs D., Kravitz H.M., and Fogg L. Suicide: A four-pathway clinical-biochemical model. Ann NY Acad Sci 836 (1997) 288-301
91. Coccaro E.F. Central serotonin and impulsive aggression. Br J Psychiatry 155 Suppl. 8 (1989) 52-62
92. Mann J.J., Marzuk P.M., Arango V., McBride P.A., Leon A.C., and Tierney H. Neurochemical studies of violent and nonviolent suicide. Psychopharmacol Bull 25 (1989) 407-413
93. Ringo D.L., Lindley S.E., Faull K.F., and Faustman W.O. Cholesterol and serotonin: Seeking a possible link between blood cholesterol and CSF 5-HIAA. Biol Psychiatry 35 (1994) 957-959
94. Terao T., Nakamura J., Yoshimura R., et al. Relationship between serum cholesterol levels and meta-chlorophenypiperazine-induced cortisol responses in healthy men and women. Psychiatry Res 96 (2000) 167-173
95. Papakostas G.I., Petersen T., Mischoulon D., et al. Serum cholesterol and serotonergic function in major depressive disorder. Psychiatry Res 118 (2003) 137-145
96. Buydens-Branchey L., Branchey M., Hudson J., and Fergeson P. Low HDL cholesterol, aggression and altered central serotonergic activity. Psychiatry Res 102 (2000) 153-162
97. Steegmans P.H., Hoes A.W., Bak A.A., van der Does E., and Grobbee D.E. Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels. Psychosom Med 62 (2000) 205-211
98. Brunner J., Parhofer K.G., Schwandt P., and Bronisch T. Cholesterol, essential fatty acids, and suicide. Pharmacopsychiatry 35 (2002) 1-5
99. Manfredini R., Caracciolo S., Salmi R., Boari B., Tomelli A., and Gallerani M. The association of low serum cholesterol with depression and suicidal behaviours: New hypotheses for the missing link. J Int Med Res 28 (2000) 247-257
100. Horsten M., Wamala S.P., Vingerhoets A., and Orth-Gomer K. Depressive symptoms, social support, and lipid profile in healthy middle-aged women. Psychosom Med 59 (1997) 521-528
101. Walton K.G., and Pugh N.D. Stress, steroids, and "ojas": Neuroendocrine mechanisms and current promise of ancient approaches to disease prevention. Indian J Physiol Pharmacol 39 (1995) 3-36
102. Francis K.T. Psychologic correlates of serum indicators of stress in man: A longitudinal study. Psychosom Med 41 (1979) 617-628
103. Agarwal V., Gupta B., Singhal U., and Bajpai S.K. Examination stress: Changes in serum cholesterol, triglycerides and total lipids. J Physiol Pharmacol 41 (1997) 404-408
104. Prabhakaran K., Suthanthirarajan N., and Namasivayam A. Biochemical changes in acute noise stress in rats. Indian J Physiol Pharmacol 32 (1988) 100-104
105. Hershock D., and Vogel W.H. The effects of immobilization stress on serum triglycerides, nonesterified fatty acids, and total cholesterol in male rats after dietary modifications. Life Sci 45 (1989) 157-165
106. Brennan Jr. F.X., Fleshner M., Watkins L.R., and Maier S.F. Macrophage stimulation reduces the cholesterol levels of stressed and unstressed rats. Life Sci 58 (1996) 1771-1776
107. Abd el Mohsen M.M., Fahim A.T., Motawi T.M., and Ismail N.A. Nicotine and stress: Effect on sex hormones and lipid profile in female rats. Pharmacol Res 35 (1997) 121-128
108. Ricart-Jane D., Rodriguez-Sureda V., Benavides A., Peinado-Onsurbe J., Lopez-Tejero M.D., and Llobera M. Immobilization stress alters intermediate metabolism and circulating lipoproteins in the rat. Metabolism 51 (2002) 925-931
109. Cassano Jr. W.J., and D'mello A.P. Acute stress-induced facilitation of the hypothalamic-pituitary-adrenal axis: Evidence for the roles of stressor duration and serotonin. Neuroendocrinology 74 (2001) 167-177
110. Djordjevic J., Cvijic G., and Davidovic V. Different activation of ACTH and corticosterone release in response to various stressors in rats. Physiol Res 52 (2003) 67-72
111. Rosmond R., Eriksson E., and Bjorntorp P. Personality disorders in relation to anthropometric, endocrine and metabolic factors. J Endocrinol Invest 22 (1999) 279-288
112. Rosmond R., and Bjorntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Int Med 247 (2000) 188-197
113. Cabana V.G., Gewurz H., and Siegel J.N. Inflammation-induced changes in rabbit CRP and plasma lipoproteins. J Immunol 130 (1983) 1736-1742
114. Erlinger T.P., Miller III E.R., Charleston J., and Appel L.J. Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids: Results from the DASH-sodium trial. Circulation 108 (2003) 150-154
115. Kisilevsky R. Serum amyloid A (SAA), a protein without a function: Some suggestions with reference to cholesterol metabolism. Med Hypotheses 35 (1991) 337-341
116. van Leeuwen H.J., Heezius E.C., Dallinga G.M., van Strijp J.A., Verhoef J., and van Kessel K.P. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 31 (2003) 1359-1366
117. Lindhorst E., Young D., Bagshaw W., Hyland M., and Kisilevsky R. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta 1339 (1997) 143-154
118. Hardardottir I., Grunfeld C., and Feingold K.R. Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 5 (1994) 207-215
119. Pajkrt D., Doran J.E., Koster F., et al. Anti-inflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 184 (1996) 1601-1608
120. Feingold K.R., Hardardottir I., and Grunfeld C. Beneficial effects of cytokine induced hyperlipidemia. Z. Ernahrungswiss 37 Suppl. 1 (1998) 66-74
121. Kaplan M., and Aviram M. Oxidized low-density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med 37 (1999) 777-787
122. Khovidhunkit W., Shigenaga J.K., Moser A.H., Feingold K.R., and Grunfeld C. Cholesterol efflux by acute-phase high density lipoprotein: Role of lecithin: Cholesterol acyltransferase. J Lipid Res 42 (2001) 967-975
123. Mallat Z., Gojova A., Brun V., et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108 (2003) 1232-1237
124. Fazio S., and Linton M.F. The inflamed plaque: Cytokine production and cellular cholesterol balance in the vessel wall. Am J Cardiol 88 (2001) 12E-15E
125. Cerwinka W.H., Cheema M.H., and Granger D.N. Hypercholesterolemia alters endotoxin-induced endothelial cell adhesion molecule expression. Shock 16 (2001) 44-50
126. Duval C., Chinetti G., Trottein F., Fruchart J.C., and Staels B. The role of PPARs in atherosclerosis. Trends Mol Med 8 (2002) 422-430
127. Diep Q.N., Amiri F., Touyz R.M., et al. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 40 (2002) 866-871
128. Lee C.H., Chawla A., Urbiztondo N., Liao D., Boisvert W.A., and Evans R.M. Transcriptional repression of atherogenic inflammation: Modulation by PPARdelta. Science 302 (2003) 453-457
129. Klappacher G.W., and Glass C.K. Roles of peroxisome proliferator-activated receptor gamma in lipid homeostasis and inflammatory responses of macrophages. Curr Opin Lipidol 13 (2002) 305-312
130. Mason J.C. Statins and their role in vascular protection. Clin Sci 105 (2003) 251-266
131. Kleemann R., Princen H.M., Emeis J.J., et al. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: Evidence for anti-inflammatory effects of rosuvastatin. Circulation 108 (2003) 1368-1374
132. Huang T.L. Lower serum albumin levels in patients with mood disorders. Chang Gung Med J 25 (2002) 509-513
133. Gurr M.I., Harwood J.L., and Frayn K.N. Lipid biochemistry. fifth Ed. (2002), Blackwell Science, Oxford 170-214
134. Spector A.A. Plasma lipid transport. Clin Physiol Biochem 2 (1984) 123-134
135. Deliconstantinos G. Effect of rat serum albumin-cholesterol on the physical properties of biomembranes. Biochem Int 15 (1987) 467-474
136. Mahley R.W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
137. Kaul D. Molecular link between cholesterol, cytokines and atherosclerosis. Mol Cell Biochem 219 (2001) 65-71
138. Steinmetz A., Hocke G., Saile R., Puchois P., and Fruchart J.C. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta 1006 (1989) 173-178
139. Etingin O.R., and Hajjar D.P. Evidence for cytokine regulation of cholesterol metabolism in herpesvirus-infected arterial cells by the lipoxygenase pathway. J Lipid Res 31 (1990) 299-305
140. Grove R.I., Mazzucco C., Allegretto N., et al. Macrophage-derived factors increase low-density lipoprotein uptake and receptor number in cultured human liver cells. J Lipid Res 32 (1991) 1889-1897
141. Babiker A., Andersson O., Lund E., et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high-density lipoprotein-mediated reverse cholesterol transport. J Biol Chem 272 (1997) 26253-26261
142. Hirai A., Kino T., Tokinaga K., Tahara K., Tamura Y., and Yoshida S. Regulation of sterol carrier protein 2 (SCP2) gene expression in rat peritoneal macrophages during foam cell formation. A key role for free cholesterol content. J Clin Invest 94 (1994) 2215-2223
143. Netea M.G., Demacker P.N., Kullberg B.J., et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest 97 (1996) 1366-1372
144. Pomerantz K.B., Nicholson A.C., and Hajjar D.P. Signal transduction in atherosclerosis: Second messengers and regulation of cellular cholesterol trafficking. Adv Exp Med Biol 369 (1995) 49-64
145. Hajjar D.P., and Haberland M.E. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. J Biol Chem 272 (1997) 22975-22978
146. van Rossum E.F., Koper J.W., Huizenga N.A., et al. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51 (2002) 3128-3134
147. Zabalawi M., Bhat S., Loughlin T., et al. Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol. Am J Pathol 163 (2003) 1201-1213
148. Major A.S., Fazio S., and Linton M.F. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 22 (2002) 1892-1898
149. Davis R.A., Miyake J.H., Hui T.Y., and Spann N.J. Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP. J Lipid Res 43 (2002) 533-543
150. Tam S.P., Flexman A., Hulme J., and Kisilevsky R. Promoting export of macrophage cholesterol: The physiological role of a major acute-phase protein, serum amyloid. A J Lipid Res 43 (2002) 1410-1420
151. Sehgal P.B., Guo G.G., Shah M., Kumar V., and Patel K. Cytokine signaling: STATS in plasma membrane rafts. J Biol Chem 277 (2002) 12067-12074
152. Diomede L., Albani D., Bianchi M., and Salmona M. Endotoxin regulates the maturation of sterol regulatory element binding protein-1 through the induction of cytokines. Eur Cytokine Netw 12 (2001) 625-630
153. Santamarina-Fojo S., Remaley A.T., Neufeld E.B., and Brewer Jr. H.B. Regulation and intracellular trafficking of the ABCA1 transporter. J Lipid Res 42 (2001) 1339-1345
154. Huber S.A., Sakkinen P., David C., Newell M.K., and Tracy R.P. T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103 (2001) 2610-2616
155. Vainio S., and Ikonen E. Macrophage cholesterol transport: A critical player in foam cell formation. Ann Med 35 (2003) 146-155
156. Grant P.J. The genetics of atherothrombotic disorders: A clinician's view. J Thromb Haemost 1 (2003) 1381-1390